CYTARIS Trademark

Trademark Overview


On Friday, July 19, 2019, a trademark application was filed for CYTARIS with the United States Patent and Trademark Office. The USPTO has given the CYTARIS trademark a serial number of 79266161. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Thursday, June 11, 2020. This trademark is owned by EXOPHARM LIMITED. The CYTARIS trademark is filed in the Pharmaceutical Products category with the following description:

Cellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart disease
cytaris

General Information


Serial Number79266161
Word MarkCYTARIS
Filing DateFriday, July 19, 2019
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateThursday, June 11, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2019

Trademark Statements


Goods and ServicesCellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, June 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameExopharm Limited
Party Type20 - Owner at Publication
Legal Entity Type83 - NOT AVAILABLE
AddressAU

Party NameEXOPHARM LIMITED
Party Type10 - Original Applicant
Legal Entity Type83 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Sunday, August 14, 2022NEW REPRESENTATIVE AT IB RECEIVED
Sunday, July 4, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 11, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 11, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 18, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, June 11, 2020ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Thursday, June 11, 2020ABANDONMENT - AFTER INTER PARTES DECISION
Thursday, June 11, 2020OPPOSITION TERMINATED NO. 999999
Thursday, June 11, 2020OPPOSITION DISMISSED NO. 999999
Friday, May 15, 2020NOTIFICATION PROCESSED BY IB
Friday, April 10, 2020REFUSAL PROCESSED BY IB
Friday, March 20, 2020OPPOSITION INSTITUTED NO. 999999
Tuesday, March 17, 2020OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Tuesday, March 17, 2020OPPOSITION NOTICE (IB REFUSAL) CREATED
Tuesday, November 19, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 30, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 30, 2019NOTICE OF PUBLICATION
Friday, October 11, 2019ASSIGNED TO LIE
Wednesday, October 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 4, 2019ASSIGNED TO EXAMINER
Friday, September 13, 2019APPLICATION FILING RECEIPT MAILED
Monday, September 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 29, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB